Cargando…
Dendritic Cells and Antiphospholipid Syndrome: An Updated Systematic Review
Antiphospholipid syndrome (APS) is an autoimmune disease characterized by autoreactive B and T cells against β2-glycoprotein I (B2GPI), with vascular thrombosis or obstetrical complications. Dendritic cells (DCs) are crucial in the generation of autoimmunity. Here, we conducted a comprehensive syste...
Autores principales: | Tang, Kuo-Tung, Chen, Hsin-Hua, Chen, Tzu-Ting, Bracci, Nicole R., Lin, Chi-Chien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8400181/ https://www.ncbi.nlm.nih.gov/pubmed/34440545 http://dx.doi.org/10.3390/life11080801 |
Ejemplares similares
-
Crassolide Suppresses Dendritic Cell Maturation and Attenuates Experimental Antiphospholipid Syndrome
por: Lin, Chi-Chien, et al.
Publicado: (2021) -
Tolerogenic β2-glycoprotein I DNA vaccine and FK506 as an adjuvant attenuates experimental obstetric antiphospholipid syndrome
por: Chao, Ya-Hsuan, et al.
Publicado: (2018) -
An update on the management of antiphospholipid syndrome
por: Rodziewicz, Mia, et al.
Publicado: (2020) -
Neurologic Manifestations of the Antiphospholipid Syndrome — an Update
por: Leal Rato, Miguel, et al.
Publicado: (2021) -
An update on the biologics for the treatment of antiphospholipid syndrome
por: Yun, Zelin, et al.
Publicado: (2023)